Back to speakers

Georgios PAPATHEODORIDIS

Associate Professor in Medicine & Gastroenterology

Greece

City: Athens

Institution: Athens University Medical School, Laiko General / Hospital, Athens, Greece

Contact: gepapath@med.uoa.gr


Biography of Georgios PAPATHEODORIDIS

George Papatheodoridis is Associate Professor in Medicine and Gastroenterology at the Medical School of Athens University and the chair of the Academic Gastroenterology Department at Laiko Hospital of Athens.

 

He graduated in Medicine and completed his PhD thesis at the Medical School of Athens University. He trained in Gastroenterology at Tzaneion General Hospital in Piraeus, Greece, and had a 2-year research fellowship in Hepatology at the Royal Free Hospital in London, UK.

 

He served as a member of the Scientific Committee/Governing Board of EASL, the General Secretary of the Hellenic Society of Gastroenterology, the General Secretary of the Hellenic Association for the Study of the Liver and the Chairman of its research committee. He is a member of EASL, AASLD, AGA (fellow) and IASL as well as of several national associations and committees.

 

His main research interest has focused on viral hepatitis, but he has also worked in other research areas of hepatology and gastroenterology. He has authored or co-authored more than 200 articles published in international journals with more than 6,000 citations (h-index 39). He was the co-ordinator of the recent EASL hepatitis B Clinical Practice Guidelines and a member of the working group for the Greek guidelines for both hepatitis B and C. He has served as a reviewer for New Engl J Med, Lancet, Ann Intern Med, and almost all gastroenterology and hepatology journals, as well as for EASL and UEGW abstracts and the EU Framework Programmes for Research.

PHC's participations

10th PHC – 2017

Tuesday, January 31st 2017

HEPATITIS B - SESSION 1 (chairman)

LUNCH WORKSHOPS - 10-Long term benefits and side effects of NUC therapy: where are we? (chairman)

9th PHC – 2016

Monday, January 11th 2016

Lunch Workshops - Room 242A -

Tuesday, January 12th 2016

Do I treat my immunotolerant patients? -

8th PHC – 2015

Tuesday, January 13th 2015

How do I treat my HBeAg-positive patients? -

7th PHC – 2014

Tuesday, January 14th 2014

Why do I treat my patient with pegylated IFN? -

6th PHC – 2013

Tuesday, January 15th 2013

Why do I treat my patient with a NUC? -

Interactive Luncheons - Room 4

5th PHC – 2012

Monday, January 30th 2012

Interactive luncheons - Room 5 -

4th PHC – 2011

Tuesday, January 18th 2011

Why do I treat my patient with a nucleos(t)ide analogue? -

10th PHC – 2017

Tuesday, January 31st 2017

HEPATITIS B - SESSION 1 (chairman)

LUNCH WORKSHOPS - 10-Long term benefits and side effects of NUC therapy: where are we? (chairman)

11th PHC – 2018

Tuesday, January 16th 2018

HEPATITIS B - SESSION 1 (chairman)

Who and when to treat ?

CONTROVERSY: To stop or not to stop NUCs ? (chairman)